| 1 |
35432298 | Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV. | 2022 |
2 |
| 2 |
33637050 | Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis. | 2021 Feb 26 |
2 |
| 3 |
34784398 | Evaluation of several serum interleukins as markers for treatment effectiveness in naïve HIV infected patients: A pilot study. | 2021 |
1 |
| 4 |
34880680 | Time to Immunologic Recovery and Its Determinant Factors Among Adult HIV Patients Who Initiated Antiretroviral Treatment at Hiwot Fana Specialized University Hospital, Harar, Ethiopia. | 2021 |
1 |
| 5 |
32577427 | Factors Associated With Weight Gain in People Treated With Dolutegravir. | 2020 Jun |
1 |
| 6 |
32667674 | Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study. | 2020 Oct 1 |
1 |
| 7 |
31146698 | Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis. | 2019 May 30 |
2 |
| 8 |
31217351 | Effect of HIV infection and antiretroviral therapy on immune cellular functions. | 2019 Jun 20 |
1 |
| 9 |
29558972 | Dolutegravir-based anti-retroviral therapy is effective and safe in HIV-infected paediatric patients. | 2018 Mar 20 |
1 |
| 10 |
29698323 | Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio? | 2018 May 15 |
1 |
| 11 |
26365498 | Missing CD4+ cell response in randomized clinical trials of maraviroc and dolutegravir. | 2015 Oct |
1 |
| 12 |
25188312 | 48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis. | 2014 |
1 |